- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01986179
Comparing Remote Interpreter Modalities in the Pediatric Emergency Department
Impact of Remote Interpreter Modality on Comprehension, Communication Quality, and Consistency of Interpreter Use in the Pediatric Emergency Department
Professional interpretation improves quality of care for patients with limited English proficiency (LEP). However, many health care settings lack access to professional interpreters, and even in locations with good access, logistical factors and perceived barriers have limited their widespread use. Remote methods of professional interpretation, including telephone and video, hold great promise for expanding access, but only limited data exist on the relative impacts of these modalities on patient care and provider uptake. Comparing how these modalities impact multiple aspects of health care quality, including family comprehension, provider communication, and consistency of provider interpreter use will inform dissemination of strategies for delivery of safe, efficient, and equitable care to LEP families.
Aim 1: To determine whether randomly assigned remote interpreter modality (telephone versus video) impacts parent-reported quality of communication and interpretation, diagnosis comprehension, and length of stay (LOS) among LEP Spanish-speaking families seen in a pediatric Emergency Department (ED).
Hypothesis 1: Parent-reported quality of communication and interpretation and parent diagnosis comprehension will be higher among families assigned to video interpretation compared to telephone interpretation.
Hypothesis 2: LOS will not differ between families assigned to video and telephone interpretation.
Aim 2: To determine whether assigned interpreter modality is associated with provider decision to communicate without professional interpretation.
Hypothesis 3: Parent-reported provider communication without professional interpretation (e.g. using the patient or a family member to interpret for some part of the visit) will be lower for families assigned to video interpretation compared to telephone interpretation.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Washington
-
Seattle, Washington, Estados Unidos, 98105
- Seattle Children's Hospital Emergency Department
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion Criteria:
- Preferred language for medical care of Spanish
- At least one primary caregiver requires interpretation
- Presenting to Seattle Children's ED during recruiting hours
Exclusion Criteria:
- Triage level 1 (life-threatening illness)
- No parent or legal guardian present
- Reason for visit is concern for abuse
- reason for visit is primary behavioral or psychiatric complaint
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Comparador activo: Telephone Interpretation
These families will be assigned to use telephone interpretation throughout the ED visit.
|
Professional interpretation provided over the phone by a national network of certified medical interpreters
|
Experimental: Video Interpretation
These families will be assigned to use video interpretation throughout the ED visit.
|
Professional interpretation provided over video by a national network of certified medical interpreters
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Communication Quality
Periodo de tiempo: Once, 1-7 days after the ED visit
|
We will use the Consumer Assessment of Healthcare Providers and Systems (CAHPS) Child Visit Survey 2.0 communication composite, which includes 5 items.
|
Once, 1-7 days after the ED visit
|
Interpretation Quality
Periodo de tiempo: Once, 1-7 days after ED visit
|
Interpretation quality will be measured with the Interpreter Satisfaction Survey (7 items).
|
Once, 1-7 days after ED visit
|
Diagnosis Comprehension
Periodo de tiempo: Once, 1-7 days after ED visit
|
Parents will be asked to name their child's diagnosis.
Clinician-recorded diagnosis will be obtained from chart review for comparison.
Responses will be classified as correct, incorrect, or vague/incomplete, using a method we have employed previously.
|
Once, 1-7 days after ED visit
|
Consistency of Interpreter Use
Periodo de tiempo: Once, 1-7 days after ED visit
|
Parents will be asked to report on the frequency with which providers used each of a list of potential communication methods (e.g.
telephone interpreter, family or friend, spoke in English without an interpreter present).
Response options are never, sometimes, frequently, or always.
|
Once, 1-7 days after ED visit
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Length of ED stay
Periodo de tiempo: Once, after ED visit
|
Time from arrival in Emergency Department to discharge home or admission to the hospital.
|
Once, after ED visit
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: K. Casey Lion, MD, MPH, Seattle Children's Hospital
Publicaciones y enlaces útiles
Publicaciones Generales
- Lion KC, Gritton J, Scannell J, Brown JC, Ebel BE, Klein EJ, Mangione-Smith R. Patterns and Predictors of Professional Interpreter Use in the Pediatric Emergency Department. Pediatrics. 2021 Feb;147(2). pii: e20193312. doi: 10.1542/peds.2019-3312.
- Lion KC, Brown JC, Ebel BE, Klein EJ, Strelitz B, Gutman CK, Hencz P, Fernandez J, Mangione-Smith R. Effect of Telephone vs Video Interpretation on Parent Comprehension, Communication, and Utilization in the Pediatric Emergency Department: A Randomized Clinical Trial. JAMA Pediatr. 2015 Dec;169(12):1117-25. doi: 10.1001/jamapediatrics.2015.2630.
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Estimar)
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 14647
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
producto fabricado y exportado desde los EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .